Cargando…
Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians
BACKGROUND: Type 2 Diabetes is a metabolic disorder characterized by hyperglycemia that causes numerous complications with significant long-term morbidity and mortality. The disorder is primarily due to insulin resistance particularly in liver, skeletal muscle, and adipose tissue. In this review, we...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856758/ https://www.ncbi.nlm.nih.gov/pubmed/33531076 http://dx.doi.org/10.1186/s40842-020-00116-1 |
_version_ | 1783646308719919104 |
---|---|
author | Albosta, Michael Bakke, Jesse |
author_facet | Albosta, Michael Bakke, Jesse |
author_sort | Albosta, Michael |
collection | PubMed |
description | BACKGROUND: Type 2 Diabetes is a metabolic disorder characterized by hyperglycemia that causes numerous complications with significant long-term morbidity and mortality. The disorder is primarily due to insulin resistance particularly in liver, skeletal muscle, and adipose tissue. In this review, we detail the hormonal mechanisms leading to the development of diabetes and discuss whether intermittent fasting should be considered as an alternative, non-medicinal treatment option for patients with this disorder. METHODS: We searched PubMed, Ovid MEDLINE, and Google Scholar databases for review articles, clinical trials, and case series related to type 2 diabetes, insulin resistance, and intermittent fasting. Articles were carefully reviewed and included based on relevance to our topic. We excluded abstracts and any non-English articles. RESULTS: The majority of the available research demonstrates that intermittent fasting is effective at reducing body weight, decreasing fasting glucose, decreasing fasting insulin, reducing insulin resistance, decreasing levels of leptin, and increasing levels of adiponectin. Some studies found that patients were able to reverse their need for insulin therapy during therapeutic intermittent fasting protocols with supervision by their physician. CONCLUSION: Current evidence suggests that intermittent fasting is an effective non-medicinal treatment option for type 2 diabetes. More research is needed to delineate the effects of intermittent fasting from weight loss. Physicians should consider educating themselves regarding the benefits of intermittent fasting. Diabetic patients should consult their physician prior to beginning an intermittent fasting regimen in order to allow for appropriate oversight and titration of the patients medication regimen during periods of fasting. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40842-020-00116-1. |
format | Online Article Text |
id | pubmed-7856758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78567582021-02-04 Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians Albosta, Michael Bakke, Jesse Clin Diabetes Endocrinol Review Article BACKGROUND: Type 2 Diabetes is a metabolic disorder characterized by hyperglycemia that causes numerous complications with significant long-term morbidity and mortality. The disorder is primarily due to insulin resistance particularly in liver, skeletal muscle, and adipose tissue. In this review, we detail the hormonal mechanisms leading to the development of diabetes and discuss whether intermittent fasting should be considered as an alternative, non-medicinal treatment option for patients with this disorder. METHODS: We searched PubMed, Ovid MEDLINE, and Google Scholar databases for review articles, clinical trials, and case series related to type 2 diabetes, insulin resistance, and intermittent fasting. Articles were carefully reviewed and included based on relevance to our topic. We excluded abstracts and any non-English articles. RESULTS: The majority of the available research demonstrates that intermittent fasting is effective at reducing body weight, decreasing fasting glucose, decreasing fasting insulin, reducing insulin resistance, decreasing levels of leptin, and increasing levels of adiponectin. Some studies found that patients were able to reverse their need for insulin therapy during therapeutic intermittent fasting protocols with supervision by their physician. CONCLUSION: Current evidence suggests that intermittent fasting is an effective non-medicinal treatment option for type 2 diabetes. More research is needed to delineate the effects of intermittent fasting from weight loss. Physicians should consider educating themselves regarding the benefits of intermittent fasting. Diabetic patients should consult their physician prior to beginning an intermittent fasting regimen in order to allow for appropriate oversight and titration of the patients medication regimen during periods of fasting. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40842-020-00116-1. BioMed Central 2021-02-03 /pmc/articles/PMC7856758/ /pubmed/33531076 http://dx.doi.org/10.1186/s40842-020-00116-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Article Albosta, Michael Bakke, Jesse Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians |
title | Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians |
title_full | Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians |
title_fullStr | Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians |
title_full_unstemmed | Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians |
title_short | Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians |
title_sort | intermittent fasting: is there a role in the treatment of diabetes? a review of the literature and guide for primary care physicians |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856758/ https://www.ncbi.nlm.nih.gov/pubmed/33531076 http://dx.doi.org/10.1186/s40842-020-00116-1 |
work_keys_str_mv | AT albostamichael intermittentfastingistherearoleinthetreatmentofdiabetesareviewoftheliteratureandguideforprimarycarephysicians AT bakkejesse intermittentfastingistherearoleinthetreatmentofdiabetesareviewoftheliteratureandguideforprimarycarephysicians |